Submitted by Anonymous (not verified) on 15 September 2026 - 15:44
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 5, Status: Authorised